Thai PBS Thai PBS
Roche reports promising results from anti-Covid cocktail

Roche reports promising results from anti-Covid cocktail

1 Oct 22:13 Key points summarised by AI
  • Roche's anti-Covid cocktail, developed with Regeneron, demonstrated a 70% reduction in hospitalisation or death for high-risk, non-hospitalised COVID-19 patients in Phase 3 trials.
  • The treatment significantly shortened symptom duration by four days and is noted as the only monoclonal antibody combination effective against major emerging variants.
Read full article
World 1/4
Skip > Skip >